Cited by 84Diabetes and associated disordersDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study

Open access
Luk, Andrea O. Y., Ke, Calvin, Lau, Eric S. H., Wu, Hongjiang, Goggins, William, Ma, Ronald C. W., Chow, Elaine, Kong, Alice P. S. +2 more·2020·PLOS Medicine

Abstract

BACKGROUND: There is very limited data on the time trend of diabetes incidence in Asia. Using population-level data, we report the secular trend of the incidence of type 1 and type 2 diabetes in Hong Kong between 2002 and 2015. METHODS AND FINDINGS: The Hong Kong Diabetes Surveillance Database hosts clinical information on people with diabetes receiving care under the Hong Kong Hospital Authority, a statutory body that governs all public hospitals and clinics. Sex-specific incidence rates were standardised to the age structure of the World Health Organization population. Joinpoint regression analysis was used to describe incidence trends. A total of 562,022 cases of incident diabetes (type 1 diabetes [n = 2,426]: mean age at diagnosis is 32.5 years, 48.4% men; type 2 diabetes [n = 559,596]: mean age at diagnosis is 61.8 years, 51.9% men) were included. Among people aged <20 years, incidence of both type 1 and type 2 diabetes increased. For type 1 diabetes, the incidence increased from 3.5 (95% CI 2.2-4.9) to 5.3 (95% CI 3.4-7.1) per 100,000 person-years (average annual percentage change [AAPC] 3.6% [95% CI 0.2-7.1], p < 0.05) in boys and from 4.3 (95% CI 2.7-5.8) to 6.4 (95% CI 4.3-8.4) per 100,000 person-years (AAPC 4.7% [95% CI 1.7-7.7], p < 0.05] in girls; for type 2 diabetes, the incidence increased from 4.6 (95% CI 3.2-6.0) to 7.5 (95% CI 5.5-9.6) per 100,000 person-years (AAPC 5.9% [95% CI 3.4-8.5], p < 0.05) in boys and from 5.9 (95% CI 4.3-7.6) to 8.5 (95% CI 6.2-10.8) per 100,000 person-years (AAPC 4.8% [95% CI 2.7-7.0], p < 0.05) in girls. In people aged 20 to <40 years, incidence of type 1 diabetes remained stable, but incidence of type 2 diabetes increased over time from 75.4 (95% CI 70.1-80.7) to 110.8 (95% CI 104.1-117.5) per 100,000 person-years (AAPC 4.2% [95% CI 3.1-5.3], p < 0.05) in men and from 45.0 (95% CI 41.4-48.6) to 62.1 (95% CI 57.8-66.3) per 100,000 person-years (AAPC 3.3% [95% CI 2.3-4.2], p < 0.05) in women. In people aged 40 to <60 years, incidence of type 2 diabetes increased until 2011/2012 and then flattened. In people aged ≥60 years, incidence was stable in men and declined in women after 2011. No trend was identified in the incidence of type 1 diabetes in people aged ≥20 years. The present study is limited by its reliance on electronic medical records for identification of people with diabetes, which may result in incomplete capture of diabetes cases. The differentiation of type 1 and type 2 diabetes was based on an algorithm subject to potential misclassification. CONCLUSIONS: There was an increase in incidence of type 2 diabetes in people aged <40 years and stabilisation in people aged ≥40 years. Incidence of type 1 diabetes continued to climb in people aged <20 years but remained constant in other age groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003052

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Hong Kong, annual type 1 diabetes mellitus incidence varied between 0.73 and 1.83 per 100,000 among men and between 0.64 and 1.09 per 100,000 among women aged ≥60 years between 2013 and 2015.

    “In a population-based Hong Kong study, annual incidence varied between 0.73 and 1.83 per 100,000 persons among men and between 0.64 and 1.09 per 100,000 persons among women aged ≥60 years19 between 2013 and 2015.”

    From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [19]

    The Results section (‘Trends in incidence of type 1 diabetes’; page unavailable) reports type 1 diabetes incidence by age and sex in Hong Kong and says incidence among adults remained stable over time. Our copy does not give the claimed 2013–2015 incidence ranges for men and women aged ≥60; the 0.73 in Table 1 is a p-value, not an incidence rate. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. [2]Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA. 2013; 310: 948– 958. 10.1001/jama.2013.168118 24002281 · DOI
  2. [4]Quan J, Li TK, Pang H, Choi CH, Siu SC, Tang SY, et al Diabetes incidence and prevalence in Hong Kong, China during 2006–2014. Diabet Med. 2017; 34: 902– 908. 10.1111/dme.13284 27859570 · DOI
  3. [6]American Diabetes Association. Standards of Medical Care in Diabetes– 2010. Diabetes Care. 2010; 33 Suppl 1: S11– S61. 20042772 PMC2797382
  4. [7]The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20: 1183– 1197. 10.2337/diacare.20.7.1183 9203460 · DOI · Paper page
  5. [8]Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009; 373: 2027– 2033. 10.1016/S0140-6736(09)60568-7 19481249 · DOI · Paper page
  6. [9]Skrivarhaug T, Stene LC, Drivvoll AK, Strøm H, Joner G; Norwegian Childhood Diabetes Study Group. Incidence of type 1 diabetes in Norway among children aged 0–14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia. 2014; 57: 57– 62. 10.1007/s00125-013-3090-y 24149838 · DOI
  7. [10]Haynes A, Bulsara MK, Bower C, Jones TW, Davis EA. Regular peaks and troughs in the Australian incidence of childhood type 1 diabetes mellitus (2000–2011). Diabetologia. 2015; 58: 2513– 2516. 10.1007/s00125-015-3709-2 26228717 · DOI
  8. [11]Rush T, McGeary M, Sicignano N, Buryk MA. A plateau in new onset type 1 diabetes: Incidence of pediatric diabetes in the United States Military Health System. Pediatric Diabetes. 2018; 19: 917– 922. 10.1111/pedi.12659 29446519 · DOI
  9. [12]Zhao Z, Sun C, Wang C, Li P, Wang W, Ye J, et al Rapidly rising incidence of childhood type 1 diabetes in Chinese population: epidemiology in Shanghai during 1997–2011. Acta Diabetol. 2014; 51: 947– 953. 10.1007/s00592-014-0590-2 24777734 · DOI
  10. [13]Kim JH, Lee CG, Lee YA, Yang SW, Shin CH. Increasing incidence of type 1 diabetes among Korean children and adolescents: analysis of data from a nationwide registry in Korea. Pediatric Diabetes. 2016; 17: 519– 524. 10.1111/pedi.12324 26420382 · DOI
  11. [14]Huen KF, Low LC, Wong GW, Tse WW, Yu AC, Lam YY, et al Epidemiology of diabetes mellitus in children in Hong Kong: the Hong Kong childhood diabetes register. J Pediatr Endocrinol Metab. 2000; 13: 297– 302. 10714755
  12. [15]Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia. 2001; 44: 914– 922. 10.1007/s001250100548 11508279 · DOI · Paper page
  13. [16]So HK, Nelson EA, Li AM, Wong EM, Lau JT, Guldan GS, et al Secular changes in height, weight and body mass index in Hong Kong children. BMC Public Health. 2008; 8: 320 10.1186/1471-2458-8-320 18803873 PMC2572616 · DOI
  14. [18]Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al; SEARCH for Diabetes in Youth Study. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017; 376: 1419– 1429. 10.1056/NEJMoa1610187 28402773 PMC5592722 · DOI · Paper page
  15. [19]Wu H, Zhong J, Yu M, Wang H, Gong W, Pan J, et al Incidence and time trends of type 2 diabetes mellitus in youth aged 5–19 years: a population-based registry in Zhejiang, China, 2007 to 2013. BMC Pediatrics. 2017; 17: 85 10.1186/s12887-017-0834-8 28330444 PMC5361693 · DOI
  16. [20]Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care. 1993; 16: 310– 314. 10.2337/diacare.16.1.310 8422798 · DOI · Paper page
  17. [21]Tam WH, Ma RC, Yang X, Li AM, Ko GT, Kong AP, et al Glucose intolerance and cardiometabolic risk in adolescents exposed to maternal gestational diabetes: a 15-year follow-up study. Diabetes Care. 2010; 33: 1382– 1384. 10.2337/dc09-2343 20215448 PMC2875460 · DOI
  18. [22]Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA. 2008; 300: 814– 822. 10.1001/jama.300.7.814 18714061 · DOI
  19. [23]Janus ED, for the Hong Kong Cardiovascular Risk Factor Prevalence Study Group. Epidemiology of cardiovascular risk factors in Hong Kong. Clin Exp Pharmacol Physiol. 1997; 24: 987– 988. 10.1111/j.1440-1681.1997.tb02736.x 9406673 · DOI
  20. [24]Ko GT, Tang JS, Chan JC. Worsening trend of central obesity despite stable or decline body mass index in Hong Kong Chinese between 1996 and 2005. Eur J Clin Nutr. 2010; 64: 549– 552. 10.1038/ejcn.2010.49 20332802 · DOI
  21. [26]Doblhammer G, Gumà J. A demographic perspective on gender, family and health in Europe. Springer Open; 2018.
  22. [27]Cho NH, Chan JC, Jang HC, Lim S, Kim HL, Choi SH. Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf). 2009; 71: 679– 685. 19508609
  23. [32]Alangh A, Chiu M, Shah BR. Rapid increase in diabetes incidence among Chinese Canadians between 1996 and 2005. Diabetes Care. 2013; 36: 3015– 3017. 10.2337/dc13-0052 23723356 PMC3781544 · DOI
  24. [33]Zghebi SS, Steinke DT, Carr MJ, Rutter MK, Emsley RA, Ashcroft DM. Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014. Diabetes Obes Metab. 2017; 19: 1537– 1545. 10.1111/dom.12964 28387052 · DOI
  25. [34]Norhammar A, Bodegård J, Nyström T, Thuresson M, Eriksson JW, Nathanson D. Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013. Diabetologia. 2016; 59: 1692– 1701. 10.1007/s00125-016-3971-y 27189067 · DOI
  26. [35]Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, Albright AL, et al Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA. 2014; 312: 1218– 1226. 10.1001/jama.2014.11494 25247518 · DOI
  27. [36]Song SO, Lee Y, Kim DW, Song YD, Nam JY, Park KH, et al Trends in diabetes incidence in the last decade based on Korean National Health Insurance Claims Data. Endocrinol Metab. 2016; 31: 292– 299. PMC4923414 27302715
  28. [37]Lin CC, Li CI, Hsiao CY, Liu CS, Yang SY, Lee CC, et al Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health. 2013; 13: 318 10.1186/1471-2458-13-318 23570503 PMC3626657 · DOI
  29. [38]Wang J, Thornton JC, Russell M, Burastero S, Heymsfield S, Pierson RN Jr. Asians have lower body mass index but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr. 1994; 60: 23– 28. 10.1093/ajcn/60.1.23 8017333 · DOI
  30. [39]Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301: 2129– 2140. 10.1001/jama.2009.726 19470990 · DOI · Paper page
  31. [40]Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348: 1986– 1994. 10.1056/NEJMoa030685 12682352 · DOI
  32. [41]Nowicka P, Santoro N, Liu H, Lartaud D, Shaw MM, Goldberg R, et al Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011; 34: 1306– 1311. 10.2337/dc10-1984 21515842 PMC3114343 · DOI

Cited by

Sorted by citations

Authors
Luk, A. O. Y., Ke, C., Lau, E. S. H., Wu, H., Goggins, W., Ma, R. C. W., Chow, E., Kong, A. P. S., So, W.-Y., & Chan, J. C. N.
Affiliations
  • Chinese University of Hong Kong (HK)
  • Hospital Authority (HK)
Corresponding author
Luk, Andrea O. Y.
Venue
PLOS Medicine
Published
2020-02-20
Volume
17
Issue
2
Pages
e1003052
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W3007112529
Cited by
84
References
1
Citations by year
2026: 5 · 2025: 13 · 2024: 14 · 2023: 17 · 2022: 14 · 2021: 11 · 2020: 10
FWCI
7.62
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Amgen
  • Pfizer
  • AstraZeneca
  • Sanofi
  • Innovation and Technology Commission
  • Hospital Authority
  • Novo Nordisk
  • Chinese University of Hong Kong
  • Hong Kong Government
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 1 diabetes, type 2 diabetes, diabetes incidence, secular trends, Hong Kong, sex differences, age at diagnosis, diabetes surveillance, Asia, age-standardized incidence rate, joinpoint regression, diabetes prevention policy, public health policy evaluation, diabetes self-management education
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Hong Kong, Humans, Infant, Infant, Newborn, Male, Middle Aged, Population Growth, Regression Analysis, Retrospective Studies, Cohort Studies, Incidence, Age Distribution, Sex Distribution, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review